Condition
Second-degree Burn
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (1)
P 4 (1)
Trial Status
Completed2
Unknown1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT03048188Not ApplicableUnknownPrimary
Manuka Honey in Second- and Grafted Third-degree Burns
NCT04149808Not ApplicableWithdrawnPrimary
Mepilex Ag vs. Xeroform in Pediatric Patients That Sustain Partial Thickness Burn Injury
NCT02108535Phase 4CompletedPrimary
Comparative Analysis of Cost-effectiveness of Silver Dressing in Burns
NCT03530150Phase 2CompletedPrimary
Pirfenidone and Its Role in Burn Wound Healing
Showing all 4 trials